Doxorubicin (Dox) is widely used for the combined chemotherapy of solid tumors. However,
the use of these drug associations in lung cancer has low antitumor efficacy. To improve its …

The use of doxorubicin (DOX), one of the most effective antitumor molecules in the treatment
of metastatic breast cancer, is limited by its low tumor selectivity and its severe side effects …

Abstract Poly (ε-caprolactone)(PCL) nanoparticles (NPs) offer many possibilities for drug
transport because of their good physicochemical properties and biocompatibility …

For effective therapy for glioma, it is essential for chemotherapeutics to pass the blood-brain
barrier to target glioma cells with little side effects to surrounding normal cells. In this study …

This study aims to improve the cytotoxicity and potency of cisplatin-loaded
polybutylcyanoacrylate (PBCA) nanoparticles (NPs) for the treatment of lung cancer through …

The objective of this study is to enhance the delivery of Doxorubicin hydrochloride to
Dalton's lymphoma solid tumour through poly (butyl cyanoacrylate)(PBC) nanoparticles …

The long-term clinical use of doxorubicin (Dox), one of the most important anticancer agent
in use, is limited by dose-related acute cardiotoxicity, myelo-suppression and multidrug …

Lung cancer is the most commonly diagnosed type of cancer worldwide, non-small cell lung
cancer accounts for most lung cancers. Doxorubicin is a widely used chemotherapy agent in …

The clinical utility of doxorubicin (DOX) is restricted by its severe side effects. Continuous
efforts are aimed at developing efficacious DOX-delivery systems that may overcome the …

In this study, to increase the blood stability and circulation time of polymeric nanoparticles as
well as to investigate the effects of the structure on therapeutic indexes, 2 types of N-(2 …